Patients Often Lose in the Battle Between Pharmaceutical Companies and PBMs
Drug Topics
JULY 18, 2023
Over the last 5 years, both PBMs and drug manufacturers have implemented restrictions that raise patients’ cost burden for specialty medications.
Pharmaceutical Companies Related Topics 
FDA Approves Aprocitentan For Treatment of Uncontrolled High Blood Pressure
Drug Topics
MARCH 20, 2024
Aprocitentan (TRYVIO) from pharmaceutical company Idorsia demonstrated statistically significant and clinically meaningful reductions in blood pressure in combination with other antihypertensive therapies.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology
MAY 2, 2024
From Merck & Co to Sanofi, Pharmaceutical Technology lists the leading pharmaceutical companies spending the most on R&D in 2023.
Biologics contract manufacturing: A comprehensive guide for pharmaceutical companies
pharmaphorum
JULY 29, 2024
This comprehensive guide provides pharmaceutical companies with valuable insights into biologics contract manufacturing, including the role of CDMOs and key considerations for successful partnerships.
AstraZeneca Caps Out-of-Pocket Inhaler Costs at $35 Per Month
Drug Topics
MARCH 18, 2024
AstraZeneca is the second pharmaceutical company to cap out-of-pocket costs for eligible patients.
Opinion: Pharma’s ethically questionable sites essentially sell drugs directly to consumers
STAT
NOVEMBER 6, 2024
Some of the largest pharmaceutical companies in the U.S. This unprecedented move launches a new dystopic era: pharmaceutical companies as health care provider, no pesky physician middlemen needed. Want to self-prescribe a prescription drug? No problem!
STAT+: As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and doctors stay mum
STAT
AUGUST 31, 2023
The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.
Harm Reduction Therapeutics Begins Shipping OTC Naloxone Nasal Spray
Drug Topics
DECEMBER 21, 2023
The nonprofit pharmaceutical company plans to begin fulfilling orders for RiVive more broadly in early 2023 and will make it available across the US for free of charge or at a low breakeven cost.
Wave sees RNA editing validation in early trial results
PharmaVoice
OCTOBER 17, 2024
The results provide the first clinical evidence of RNA editing, a burgeoning field that's drawn interest from biotechs and pharmaceutical companies alike.
Pharma’s big patent cliff, more obesity fundraising, and a failed ALS study
STAT
JANUARY 9, 2025
We chat about how pharmaceutical companies are navigating a looming patent cliff. We also talk about yet another obesity startup and a failed study from Google’s secretive anti-aging company Calico. And what are the hosts’ New Year’s resolutions? Read the rest…
A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology
PharmaVoice
SEPTEMBER 10, 2024
But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. Over the past 10 years, PD1-blocking medicines have transformed cancer care.
High Demand Keeps Some Diabetes Medications in Short Supply
Drug Topics
FEBRUARY 8, 2023
Pharmaceutical companies are experiencing supply chain disruptions and shortages because of the popularity of diabetes drugs used for weight loss.
STAT+: Pharma still ‘falling short’ in providing access to low- and middle-income countries, analysis finds
STAT
NOVEMBER 19, 2024
Although more pharmaceutical companies are tailoring their business models to focus on low-income countries, a new analysis finds that overall industry efforts remain limited and patient access continues to suffer as a result.
STAT+: Truveta enlists health systems, drugmakers to launch ambitious new genomic database
STAT
JANUARY 13, 2025
The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceutical company Regeneron has invested $119.5
Medical Records 
134
134 
Generic Tiotropium Bromide Inhalation Powder For Treatment of COPD Now Available in US
Drug Topics
NOVEMBER 20, 2023
The capsule was developed by the pharmaceutical company Lupin and is a generic equivalent to Boehringer Ingelheim’s Spiriva HandiHaler.
How pharmaceutical companies can speed up construction projects
pharmaphorum
FEBRUARY 12, 2025
Learn how pharmaceutical companies can accelerate construction projects in the biotech and manufacturing sectors by implementing innovative strategies and best practices.
STAT+: European regulators approve $16.5 billion deal for Novo Holdings to buy Catalent
STAT
DECEMBER 6, 2024
The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the largest pharmaceutical companies, would pay $16.5 billion for Catalent, a leading contract drug manufacturer.
STAT+: Young biotech venture firm raises $500 million for its second fund
STAT
DECEMBER 9, 2024
Well, in Dimension’s case, they end up investing in some buzzy AI startups, counseling pharmaceutical companies, ribbing one another about expense reports, and — as of Monday — are able to raise $500 million for their second fund.
STAT+: Why Orexo is abandoning a digital therapeutic for depression
STAT
DECEMBER 3, 2024
Swedish pharmaceutical company Orexo will no longer pursue an app for treating depression after many years of struggling to sell it. Orexo announced this week that it will no longer license the product, called Deprexis, from German manufacturer GAIA.
STAT+: U.K. lawmaker wants regulators to probe pharma companies over ‘misleading’ Covid-19 vaccines statements
STAT
FEBRUARY 14, 2025
Parliament is calling for regulators to audit pharmaceutical companies that have made misleading statements to the public about their Covid-19 vaccines. A member of the U.K. And the move comes after Moderna was chastised for the second time in five months by a U.K.
Vaccines 115
115 
How Pharmaceutical Companies Can Mitigate a Potential Drop in Demand Due to Tariffs
PharmExec
MARCH 3, 2025
In this part of his Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, identifies strategies that pharmaceutical companies and digital health platforms can employ to navigate a potential drop in demand due to tariff-induced increased costs.
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing
The Guardian - Pharmaceutical Industry
MARCH 21, 2025
Pharmaceutical company will invest money over five years in strategic partnership with the citys authorities Business live latest updates AstraZeneca will invest $2.5bn in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and (..)
STAT+: Sanofi plans to change payment terms for 340B hospitals
STAT
NOVEMBER 22, 2024
The battle over prescription drug discounts offered to hospitals under a federal program escalated as Sanofi became the third pharmaceutical company to disclose plans to change the way it will make payments.
Hospitals 114
114 
STAT+: Belgian anti-trust authorities probe Roche for allegedly delaying biosimilars of two cancer meds
STAT
MARCH 17, 2025
In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceutical companies that could supply similar medicines.
Opinion: STAT+: There’s a better way to get drugs on the market: progressive approval
STAT
FEBRUARY 27, 2025
The public and pharmaceutical companies are calling for changes in drug regulation and the costs of medicines. Companies want to see products approved faster for financial reasons, and patients want medicines that can improve their lives. They are right to do so.
From the Beatles to biologics – how Liverpool became a life science hotspot
The Guardian - Pharmaceutical Industry
JANUARY 11, 2025
The city has a long history with tropical medicine and is now home to one of the largest biotech clusters in Europe Tucked away in the village of Leasowe, near Moreton on the Wirral peninsula west of Liverpool, the US pharmaceutical company Bristol Myers Squibb (BMS) is building a new 35m glass-clad laboratory building.
STAT+: Tapping the potential of GLP-1 drugs requires integrated care and overcoming inequities, executives say
STAT
MARCH 20, 2025
And reminiscent of a modern-day gold rush, there is now a headlong race among a growing number of pharmaceutical companies to determine how many other maladies the drugs may be capable of treating.
Artificial Intelligence is Changing the Face of Pharmacovigilance
Pharmacy Times
OCTOBER 17, 2022
Pharmaceutical companies are looking into AI as the new method to not only reduce research and development costs, but also prevent costly errors.
Novo Nordisk industry membership reinstated
European Pharmaceutical Review
MARCH 18, 2025
Novo Nordisk has regained full membership with the Association of the British Pharmaceutical Industry (ABPI), following suspension in 2023. This action resulted after the pharmaceutical company made serious breaches of the ABPI Code of Practice in 2021.
A Win for Indiana Patients: “Share the Savings” Legislation Now Law
PhRMA
MAY 8, 2023
Negotiations between pharmaceutical companies, health insurers, PBMs and others result in significant rebates and discounts that totaled $236 billion in 2021. However, those savings aren’t always shared with patients, which means there are patients who end up paying more for their medicine than their insurer and PBM.
Does your copay program factor in differences across specialties? GoodRx analysis shows it should.
PharmaVoice
OCTOBER 17, 2022
To address this gap, GoodRx is partnering with pharmaceutical companies to improve cost transparency and communication between patients and providers. New findings reveal an out-of-pocket cost gap between brand-name and generic prescriptions.
Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure
STAT
DECEMBER 5, 2023
And pharmaceutical companies that learned of the vaccine-making power of the messenger RNA platform during the Covid-19 pandemic need new markets for their technology. Here are two things that are true. The world needs more effective flu vaccines. Read the rest…
Vaccines 145
145 
Opinion: The Pandemic Treaty will succeed only with investment to build strong health systems
STAT
MAY 31, 2024
The vested interests of pharmaceutical companies, lobbying groups, and conservative British broadcaster Nigel Farage bleating about “defending sovereignty” are threatening to derail the treaty process entirely. The treaty has been beset by delay and misinformation.
AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines
The Guardian - Pharmaceutical Industry
MAY 7, 2024
Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied AstraZeneca has begun the worldwide withdrawal of its Covid-19 vaccine due to a “surplus of available updated vaccines” that target new variants of the virus.
Vaccines 112
112 
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
The Guardian - Pharmaceutical Industry
OCTOBER 16, 2024
Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners The pharmaceutical company behind injectable weight-loss drugs has been accused of prioritising profits over the health of people in developing countries by halting production of its insulin pens.
Sunshine transparency reporting for emerging pharma: Simplify, streamline, and secure
pharmaphorum
APRIL 10, 2024
Discover how Sunshine transparency reporting can be simplified, streamlined, and secured for emerging pharmaceutical companies with a focus on Healthcare Professionals (HCP) and Healthcare Organisations (HCO).
Listen: Biotech layoffs, founder-focused VC, & a big pharma exit
STAT
JULY 11, 2024
Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout out as its next science chief? STAT’s West Coast biotech reporter Jonathan Wosen joins “The Readout LOUD” to discuss what’s driving workforce cuts. Read the rest…
STAT+: Generic drugmakers win a long-running battle with California over a law to ban pay-to-delay deals
STAT
FEBRUARY 18, 2025
California officials were dealt a setback by a federal judge who ruled that a controversial law banning so-called pay-to-delay deals between pharmaceutical companies is, in part, unconstitutional and so cannot be enforced against agreements that had no link to the state. In his ruling , U.S.
What can pharma companies do to quicken the pace of digital disruption?
pharmaphorum
JUNE 10, 2024
Discover how pharmaceutical companies can leverage digital technologies to accelerate innovation and disrupt the industry. Learn about regulatory considerations and engagement with healthcare professionals (HCPs) for successful digital transformation.
What pharma stands to gain from technological innovation
pharmaphorum
APRIL 22, 2024
Pharmaceutical companies stand to gain significant benefits from technological innovation in the form of improved data analytics, streamlined healthcare processes, and enhanced patient outcomes. Explore the potential advantages for the pharma industry.
STAT+: Pfizer plans to depart BIO
STAT
DECEMBER 5, 2023
The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the decision.
Watch: How drug patents pave the way to profit
STAT
AUGUST 8, 2024
Discovering a new drug is a big win for a pharmaceutical company, but selling it for lots of money with no competition? This is Part 3 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. The cherry on top. Read the rest…
Cost of developing new drugs may be far lower than industry claims, trial reveals
The Guardian - Pharmaceutical Industry
APRIL 25, 2024
Exclusive: MSF calls for transparency after its bill for a trial of TB treatment came to a fraction of the billions claimed by pharmaceutical companies Doctors have for the first time released details of their spending on a major clinical trial, demonstrating that the true cost of developing a medicine may be far less than the billions of dollars claimed (..)
Long-overlooked scientist shares Lasker Award with other GLP-1 researchers
STAT
SEPTEMBER 19, 2024
Read the rest…
Let's personalize your content